Definitive Healthcare Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Definitive Healthcare Corp. on July 4, 2024, regarding events occurring on that date. The filing focuses on executive compensation adjustments related to the appointment of Kevin Coop as Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate governance and compensation event.
Material Changes
On July 4, 2024, the Company granted Kevin Coop an additional award of 186,192 time-vesting restricted stock units (RSUs). This grant was issued to compensate for a shortfall in the equity grant value originally delivered to Mr. Coop, attributed to share price volatility between the announcement of his appointment and his start date of June 24, 2024.
Outlook, Risks, and Unusual Items
- Equity Vesting Schedule: The RSU Award vests 25% on July 1, 2025, and 6.25% per quarter thereafter over the subsequent three years, contingent on continued employment.
- Management Commentary: The Company explicitly stated the grant was intended to address the impact of share price volatility on the initial compensation package.
Key Facts for Investor Verification
- Verify the total equity compensation value for the CEO, including the initial grant and this supplemental 186,192 RSU award.
- Review the May 24, 2024 Form 8-K to understand the original Employment Agreement terms referenced in this filing.
- Monitor the Company's share price volatility and its potential impact on future executive compensation adjustments.